C69.80
C69.80 — Malignant neoplasm of overlapping sites of unspecified eye and adnexa
Billable / specific codeICD-10-CMunspecified
C69.80 is a billable, specific ICD-10-CM code for malignant neoplasm of overlapping sites of unspecified eye and adnexa. It is valid for submission on a claim.
Risk adjustment
C69.80 risk-adjusts. Under the CMS-HCC V28 model it maps to this category:
- HCC 23 Prostate, Breast, and Other Cancers and Tumors0.186 RAF
Coefficient shown for the Community Non-dual Aged segment. A higher HCC in the same hierarchy will suppress this one, so capturing it does not always add score.
Medicare coverage
C69.80 is named in 35 Medicare coverage policies — 35 listing it as supporting medical necessity. Which of them applies to you depends on your Medicare contractor, and coverage genuinely differs by state.
- A52479Oral Anticancer Drugs - Policy Article
- A54768Billing and Coding: Cardiac Blood Pool Imaging (Multiple Gated Acquisition Scanning- MUGA, Ventriculography) When Performed in Conjunction with Cardiotoxic Chemotherapy
- A55717Billing and Coding: Lab: Flow Cytometry
- A56551Billing and Coding: Visual Fields Testing
Related codes at this level
Codes that share C69.8. If C69.80 is not quite right, the correct code is usually one of these.
Questions about C69.80
- Is C69.80 a billable ICD-10-CM code?
- Yes. C69.80 is a billable, specific ICD-10-CM code and is valid for submission on a claim.
- Where does C69.80 sit in the tabular list?
- Neoplasms (C00-D49), in the block Malignant neoplasms of eye, brain and other parts of central nervous system (C69-C72).